Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Theriva Biologics Inc’s stock clocked out at $0.41, down -1.01% from its previous closing price of $0.42. In other words, the price has decreased by $-1.01 from its previous closing price. On the day, 0.83 million shares were traded. TOVX stock price reached its highest trading level at $0.428 during the session, while it also had its lowest trading level at $0.41.
Ratios:
To gain a deeper understanding of TOVX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.07 and its Current Ratio is at 4.07. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 07 ’23 when SHALLCROSS STEVEN A bought 14,000 shares for $0.69 per share. The transaction valued at 9,703 led to the insider holds 250,000 shares of the business.
SHALLCROSS STEVEN A bought 26,000 shares of TOVX for $16,453 on Jun 06 ’23. The CEO and CFO now owns 236,000 shares after completing the transaction at $0.63 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 7047828 and an Enterprise Value of -11169130.
Stock Price History:
The Beta on a monthly basis for TOVX is 1.47, which has changed by -0.38235295 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $1.20, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -12.23%, while the 200-Day Moving Average is calculated to be -19.87%.
Shares Statistics:
It appears that TOVX traded 98.16K shares on average per day over the past three months and 25620 shares per day over the past ten days. A total of 17.15M shares are outstanding, with a floating share count of 16.78M. Insiders hold about 2.14% of the company’s shares, while institutions hold 6.14% stake in the company. Shares short for TOVX as of 1711584000 were 411008 with a Short Ratio of 4.19, compared to 1709164800 on 348186. Therefore, it implies a Short% of Shares Outstanding of 411008 and a Short% of Float of 2.42.
Earnings Estimates
The performance of Theriva Biologics Inc (TOVX) in the stock market is under the watchful eye of GeoVax Labs, Inc. analysts actively contributing to its current rating.The consensus estimate for the next quarter is $29.70, with high estimates of $0.00 and low estimates of $0.41.
